Docetaxel (TXT) is acknowledged as one of the most important chemotherapy agents for gastric cancer (GC). PI3K/AKT signaling is frequently activated in GC, and its inhibitor LY294002 exerts potent antitumor effects. However, the hydrophobicity of TXT and the poor solubility and low bioavailability of LY294002 limit their clinical application. To overcome these shortcomings, we developed poly(lactic acid/glycolic) (PLGA) nanoparticles loaded with TXT and LY294002. PLGA facilitated the accumulation of TXT and LY294002 at the tumor sites. The in vitro functional results showed that PLGA(TXT+LY294002) exhibited controlled-release and resulted in a markedly reduced proliferative capacity and an elevated apoptosis rate. An in vivo orthotopic GC mouse model and xenograft mouse model confirmed the anticancer superiority and tumor-targeting feature of PLGA(TXT+LY294002). Histological analysis indicated that PLGA(TXT+LY294002) was biocompatible and had no toxicity to major organs. Characterized by the combined slow release of TXT and LY294002, this novel PLGA-based TXT/LY294002 drug delivery system provides controlled release and tumor targeting and is safe, shedding light on the future of targeted therapy against GC.
LinFde GooijerMCHanekampDet al.
PI3K-mTOR pathway inhibition exhibits efficacy against high-grade glioma in clinically relevant mouse models. Clin Cancer Res2017;
23: 1286–1298.
4.
MohanSVander BroekRShahSet al.
MEK inhibitor PD-0325901 overcomes resistance to PI3K/mTOR inhibitor PF-5212384 and potentiates antitumor effects in human head and neck squamous cell carcinoma. Clin Cancer Res2015;
21: 3946–3956.
5.
GuoFJiaoDSuiGQet al.
Anticancer effect of YWHAZ silencing via inducing apoptosis and autophagy in gastric cancer cells. Neoplasma2018;
65: 693–700.
6.
ChenXZhaoLKangYet al.
Significant suppression of non-small-cell lung cancer by hydrophobic poly(ester amide) nanoparticles with high docetaxel loading. Front Pharmacol2018;
9: 118.
7.
MairaSMStaufferFSchnellCet al.
PI3K inhibitors for cancer treatment: where do we stand?Biochem Soc Trans2009;
37: 265–272.
8.
KongDYamoriT.Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy. Cancer Sci2008;
99: 1734–1740.
9.
GolombekSKMayJNTheekBet al.
Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev2018;
130: 17–38.
10.
MatsumuraYMaedaH.A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res1986;
46: 6387–6392.
11.
BowermanCJByrneJDChuKSet al.
Docetaxel-loaded PLGA nanoparticles improve efficacy in taxane-resistant triple-negative breast cancer. Nano Lett2017;
17: 242–248.
12.
RezvantalabSDrudeNIMoravejiMKet al.
PLGA-based nanoparticles in cancer treatment. Front Pharmacol2018;
9: 1260.
13.
ZuoXChenZWangJet al.
miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2. Am J Cancer Res2018;
8: 662–674.
14.
ZhangLHuYJiangXet al.
Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Rel2004;
96: 135–148.
15.
SukJSXuQKimNet al.
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev2016;
99: 28–51.
16.
ZhangLZhangMZhouLet al.
Dual drug delivery and sequential release by amphiphilic Janus nanoparticles for liver cancer theranostics. Biomaterials2018;
181: 113–125.
17.
LuoZJiangLDingCet al.
Surfactant free delivery of docetaxel by poly[(R)-3-hydroxybutyrate-(R)-3-hydroxyhexanoate]-based polymeric micelles for effective melanoma treatments. Adv Healthcare Mater2018;
7: e1801221.
18.
XingCZhuBFanXet al.
Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice. World J Gastroenterol2009;
15: 5044–5052.
19.
HiraiHSootomeHNakatsuruYet al.
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther2010;
9: 1956–1967.
20.
MacKeiganJPTaxmanDJHunterDet al.
Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin Cancer Res2002;
8: 2091–2099.
21.
XiaoBSiXHanMKet al.
Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. J Mater Chem B2015;
3: 7724–7733.
22.
SunJHZhangWZhangDYet al.
Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy. J Biomater Appl2018;
32: 1253–1264.
23.
NelsonCRobinson-HammJGersbachC.Genome engineering: a new approach to gene therapy for neuromuscular disorders. Nat Rev Neurol2017;
13: 647–661.
24.
LiTShenXGengYet al.
Folate-functionalized magnetic-mesoporous silica nanoparticles for drug/gene codelivery to potentiate the antitumor efficacy. ACS Appl Mater Interfaces2016;
8: 13748–13758.
25.
Martínez-NegroMKumarKBarrán-BerdónAet al.
Efficient cellular knockdown mediated by siRNA nanovectors of gemini cationic lipids having delocalizable headgroups and oligo-oxyethylene spacers. ACS Appl Mater Interfaces2016;
8: 22113–22126.
26.
Abu LilaASIshidaT.Liposomal delivery systems: design optimization and current applications. Biol Pharm Bull2017;
40: 1–10.
27.
FengYGaoYWangDet al.
Autophagy inhibitor (LY294002) and 5-fluorouracil (5-FU) combination-based nanoliposome for enhanced efficacy against esophageal squamous cell carcinoma. Nanoscale Res Lett2018;
13: 325.
28.
DoddapaneniBSKyryachenkoSChaganiSEet al.
A three-drug nanoscale drug delivery system designed for preferential lymphatic uptake for the treatment of metastatic melanoma. J Control Release2015;
220: 503–514.
29.
RenWShaHYanJet al.
Enhancement of radiotherapeutic efficacy for esophageal cancer by paclitaxel-loaded red blood cell membrane nanoparticles modified by the recombinant protein anti-EGFR-iRGD. J Biomater Appl2018;
33: 707–724.
30.
KeshavarzMMoloudiKPaydarRet al.
Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy. J Biomater Appl2018;
33: 161–169.
31.
JiangXZhangBZhouZet al.
Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine. Drug Deliv2017;
24: 1419–1428.
32.
LiuQLiRTQianHQet al.
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. Biomaterials2013;
34: 7191–7203.
